Leerink Partnrs Brokers Lower Earnings Estimates for VRTX
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Equities researchers at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals in a research note issued to investors on Thursday, September 25th. Leerink Partnrs analyst D. Risinger
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Equities researchers at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals in a research note issued to investors on Thursday, September 25th. Leerink Partnrs analyst D. Risinger
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
